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INTRODUCTION 
 
Nutritional support plays important roles in wound healing and 
postoperative recovery. A poor nutritional status is strongly associated 
with delayed wound healing and longer hospital stays after surgery. After 
emergency gastrointestinal (GI) surgery, nutritional status is impaired 
and basal energy expenditure is raised and thus, nutritional support is of 
considerable importance. 
Several reports have emphasized that early enteral feeding should 
be started as soon as possible after resuscitation because the 
immunomodulatory effect of enteral feeding could assist recovery. 
Patients who undergo emergency GI surgery have an edematous or 
ischemic bowel, and are at high risk of postoperative complications, such 
as ileus, obstruction. For these reasons, the majority of surgeons are wary 
of early feeding after emergency GI surgery. Relatively few reports have 
been issued on the safety of early feeding after emergency GI surgery. 
Thus, this study is undertaken to assess the feasibility of early feeding in 
patients after emergency GI surgery. 
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AIMS AND OBJECTIVES 
 
 To assess the feasibility of early enteral feeding in patients who 
have undergone emergency gastrointestinal surgeries and compare 
the complications and duration of hospital stay with that of late 
enteral feeding group in General Surgery department in GRH 
Madurai for 1 year from October 2016 to September 2017. 
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REVIEW OF LITERATURE 
Barlow, et al.11 demonstrated that operative morbidity was less common 
after major upper GI surgery in patients that received early enteral 
nutrition. In particular, chest infections were significantly less common 
in these patients. 
Moore, et al.,18 via meta-analysis of high-risk surgical patients, also 
found that early enteral feeding was associated with a lower incidence of  
pneumonia and other septic complications 
Stephen, mathias demonstrated that there seems to be no clear 
advantage to keeping patients nil by mouth after elective gastrointestinal 
resection. Early feeding may be of benefit. An adequately powered trial 
is required to confirm or disprove the benefits seen in small trial. Early 
feeding reduced the risk of any type of infection, improve wound healing 
and decrease the mean length of stay in hospital. 
Navaneeth, Maneesh, Vivek demonstrated that early enteral feeding 
through a nasoenteric tube is well tolerated by these patients and helps to 
improve energy and protein intake, reduces the amount of nasogastric 
aspirate, reduces the duration of postoperative ileus, and reduces the risk 
of serious complications. 
 
4 
 
 In my study, I am going to include the patients undergoing 
emergency gastrointestinal surgeries in acute abdomen presenting within 
24 hours and equal number ofcontrol groups, the case group being started 
enteral feeding within 48 hours and the control group started enteral 
feeding after the appearance of bowel sounds and, passing flatus.the 
variables being studied are postoperative pulmonary complications, 
wound infections, postoperative ileus and, length of hospital stay. 
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ENTERAL SUPPORT 
Gut starvation can adversely affect surgical patients. Patients who 
have not started on early enteral nutrition postoperatively have a 
significantly higher mortality rate than those who receive nutrition 
support. 
Preoperative malnutrition is also related to poor outcome. 
Worldwide studies show that 30% to 50% of hospitalized patients are 
malnourished, a condition associated with longer hospital stay, higher 
cost, and increased morbidity and mortality. Patients with malignancies, 
inflammatory bowel disease, or chronic heart failure are at particularly 
high risk. Suppressed immune function can increase risk for nosocomial 
infections and delayed wound healing. Decreased muscle function can 
lead to reduced cardiac function and greater difficulty in weaning patients 
from ventilators. It can also increase susceptibility to respiratory tract 
infection. 
Appropriate use of nutritional support can benefit malnourished 
preoperative patients and certain groups of postoperative ones. Enteral 
nutrition (EN) involves the delivery of nutrients  by  tube into  the  
gastrointestinal tract. 
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Parenteral nutrition entails the administration of nutrients intravenously. 
This chapter will review the rationale, administration, and prevention of 
complications associated with enteral nutrition. 
Rationale Mucosal Atrophy 
Guedon et al. found reduced enzyme activity but no gross 
morphologic changes in human intestinal mucosa after prolonged 
administration of total parenteral nutrition (TPN). Food in the intestinal 
lumen is critical to mucosal cell growth and function. Bowel rest and 
TPN in rats have been found to cause gut atrophy within days, an 
outcome thought to be the result of lack of functional stimulation as well 
as reduced pancreatic and biliary secretions.  
Pironi et al. report significant changes in morphologic and 
cytoproliferative patterns of duodenal mucosa with the administration of 
long-term TPN. Similar data from Groos et al. show morphologic 
changes in human intestinal mucosa, epithelial cell turnover, and 
extracellular matrix.  
The clinical repercussions of these changes are unknown and not 
all studies are consistent with these observations. 
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Bacterial Translocation 
Animal studies suggest an association between bacteria 
translocation and postoperative sepsis. O'Boyle et al. report a relation 
between translocation and postoperative sepsis, but not mortality. Data 
from human studies show a relation between gut microflora and 
nosocomial infections, a link suggesting that the gut is a reservoir of 
bacteria and endotoxins. Other data report no relation between alterations 
in intestinal barrier function and a predisposition to translocation of 
enteric bacteria.  
The prevalence of bacterial translocation is approximately 15% in 
elective surgical patients and higher in those patients with intestinal 
obstruction or a compromised immune system. Sedman et al. suggest that 
prevalence of bacterial translocation is the same in patients receiving 
either TPN or EN, i.e., that short-term use of TPN does not appear to 
produce changes in the morphology of intestinal villus or bacterial 
translocation in preoperative patients. However, there is insufficient 
evidence to determine if bacterial translocation causes septic 
complications in patients who receive TPN. 
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Infectious Complications 
A recent meta-analysis examined the relation between nutritional 
interventions, complications, and mortality rates. Twenty-seven studies 
with 1,828 patients showed a 34% lower risk of infection with EN 
compared with TPN. EN was associated with a reduced risk of infection 
regardless of nutrition status, presence of cancer, year of study 
publication, or quality of study method.  
These findings were also independent of catheter sepsis analysis. 
None of the studies in the meta-analysis examined the role of bacterial 
translocation as primary mechanism for infection in patients who receive 
TPN. Increased risk of infection may be related in part to a higher 
incidence of hyperglycemia in this population. Excess glucose load and 
stress response in TPN fed patients may lead to impaired immune 
responses that contribute to greater risk of infection Noninfectious 
Complications 
A comparison of noninfectious complications showed a 36% 
greater risk for EN compared with TPN. Such complications included 
TPN-related and EN-related technical (caused by tube or catheter 
insertion) and mechanical problems (dislodged or occluded tube or 
catheter); aspiration; diarrhea; vomiting; fistula at the catheter or tube 
site; and hyperglycemia. Many of the complications associated with EN 
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(e.g., diarrhea or abdominal distention) occur frequently, but are 
considered less severe than catheter sepsis. Because EN and TPN are not 
without risks, their advantages and disadvantages must be carefully 
weighed before the initiation of either type of nutrition support. 
Cost 
Data show that EN is less expensive to administer than TPN. Costs 
include access devices, insertion, solutions, delivery hardware, laboratory 
monitoring, clinical monitoring, and complications. 
Prolonged periods of inadequate nutrition increase risk of 
morbidity and mortality in hospitalized patients. When indicated, 
nutrition support should be considered the best practice care. If there are 
no contraindications, EN should be the treatment of first choice. Among 
other reasons, it is less expensive than TPN and is associated with fewer 
septic complications. 
Indications and Contraindications: EN should be considered in 
patients who have a functional gut; who cannot, should not, or will not 
eat adequately; and for whom there is a safe method of access. 
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General indications for EN include: 
a) protein-calorie malnutrition (>10% loss of usual weight or serum 
albumin levels <3.5 g/dL), 
b) oral intake inadequate or likely to be inadequate for 7 to 14 days, 
and 
c) a functional gastrointestinal tract (sufficient length and condition to 
allow adequate nutrient absorption). 
 
Enteral Formulas 
Large numbers of commercial enteral formulas are available for 
oral and tube feeding. All contain macronutrients and micronutrients of 
varying quantities and compositions.  
These formulas have evolved from foods prepared in a blender to 
exact macronutrient and micronutrient compositions for specific disease 
states. 
There are three major groups of enteral formulas: polymeric-
balanced, monomeric (elemental), and disease-specific. 
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Indications and Contraindications for Enteral Nutrition 
Indications for Enteral Nutrition 
1. Neurologic 
 Head injury 
 Cerebrovascular diseases 
 Demyelinating diseases 
 Neoplasms 
 Neuromuscular diseases 
2. Oropharynx and esophageal 
 Neoplasms 
 Inflammation 
 Trauma 
3. Gastrointestinal 
 Pancreatitis 
 Inflammatory bowel disease 
 Shortbowel syndrome 
 Intestinal fistulas 
 Malabsorption 
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4. Psychological 
 Anorexia nervosa 
 Severe depression 
5. Miscellaneous 
 Burns 
 Chemotherapy 
 Radiation therapy 
 Kidney disease 
 Liver disease 
 Cystic fibrosis 
 Organ transplantation 
Contraindications for enteral nutrition 
 Complete mechanical intestinal obstruction 
 Diffuse peritonitis 
 Intractable vomiting 
 Paralytic ileus 
 Intractable diarrhea 
 Gastrointestinal ischemia 
 Hemodynamic instability 
 
 
13 
 
Polymeric-Balanced Formulas 
Polymeric formulas are widely used and generally well tolerated. 
When administered as prescribed, they provide nutritionally complete 
and balanced diets that include most required micronutrients and 
macronutrients. Formulas are generally 1 kcal/mL, with 50% to 55% 
carbohydrate, 15% to 20 % protein, and 30% fat. Calorie-dense formulas 
(1.5 to 2 kcal/mL) are also available, but should be reserved for patients 
who require high energy intake or fluid restriction. Carbohydrates in 
polymeric formulas range from starches to simple sugars. 
Oligosaccharides and polysaccharides are commonly used and well 
tolerated. Proteins are usually intact—i.e., whole protein from food or 
protein isolates. Normal levels of pancreatic enzymes are required to 
digest these proteins. 
Vegetable oils, high in long-chain triglycerides (LCTs), are the 
major sources of fats. 
Mixtures of LCTs and medium-chain triglycerides (MCTs) are also 
used in enteral formulas. MCTs, which are rapidly absorbed from the 
intestinal lumen and transported directly into the blood to the liver via the 
portal vein, are the preferred substrate. Polymeric-balanced formulas are 
less expensive than other options. For approximately 90% of surgical 
patients, they are the formula of choice. 
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Monomeric (Elemental) Formulas 
Elemental formulas are more expensive than polymeric 
alternatives. They use free amino acids or small chain peptides as protein 
sources and are easy to digest. 
Elemental formulas are usually low in fat or high in MCTs. They 
are typically prescribed for patients with maldigestion and malabsorption; 
e.g., pancreatitis, critical illness, short-gut syndrome, enterocutaneous 
fistulas, and diarrhea. In patients undergoing routine gastrointestinal 
operations, elemental formulas offer no benefit over polymeric formulas. 
Similar data have been found in a study of patients who were critically ill 
with hypoalbuminemia. 
Modular Supplements 
In cases in which commercially available enteral formulas may not 
be optimal, patients may benefit from modular feeding systems. Modular 
supplements contain single or multiple nutrients (protein, carbohydrate, 
and/or fat) that can be added to liquid enteral formulas. 
Disease-Specific Formulas 
Disease-specific formulas modify nutrient profiles to achieve 
desired outcomes, such as immune enhancement, or address specific 
disease states, such as renal, hepatic, and pulmonary states. 
15 
 
Immune-Enhancing Formulas 
Various enteral formulas contain substrates with immune-
modulating properties, eg., glutamine, arginine, n-3 fatty acids, 
nucleotides, selenium, and vitamins A, C and E. Data suggest that these 
formulas reduce the incidence of infectious complications, decrease 
ventilator time, shorten hospital and intensive care stays and reduce 
patient hospital costs. At the same time, the use of immune-enhancing 
formulas in severely ill patients has been found to increase mortality, 
lengthen stays in hospital and intensive care units, extend ventilator time, 
and raise treatment costs. Data indicate that immune-enhancing diets 
benefit moderate-to-severely malnourished patients undergoing elective 
gastrointestinal surgery, those with severe blunt and penetrating torso 
trauma, and some critically ill patients. 
Renal Diets 
Patients with stable chronic renal failure typically need energy-
dense, low-protein diets, and those undergoing hemodialysis require 
high-protein diets. Use of essential amino acids or branched chain amino 
acids (BCAAs) shows no clear benefit in efforts to meet caloric needs 
and avoid protein load. Studies have yet to show clinical efficacy of renal 
failure formulas; therefore, their use should be limited to efforts to avoid 
dialysis in cases of acute renal failure, or to reduce dialysis requirements. 
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With renal dysfunction, metabolism of certain vitamins and minerals 
(e.g., folic acid, pyridoxine, calcium, and vitamins A, C, and D) and 
excretion of electrolytes (e.g., potassium, magnesium, and phosphorus) 
may be impaired. It may be necessary to adjust the intake. 
Hepatic Formulas 
Hepatic enteral formulas contain large amounts of the BCAAs—
valine, leucine, and isoleucine—and small amounts of the aromatic 
amino acids (AAAs)— phenylalanine, tyrosine, and tryptophan. The 
formulas are designed to reduce AAAs in the blood–brain barrier by 
normalizing AAA to BCAA ratios in the plasma of patients with hepatic 
encephalopathy.  
Data suggest that BCAA supplements provide necessary nitrogen 
intake to some protein-intolerant patients with no adverse effect on 
mental state, and perhaps even improvement. Because the use of BCAA 
supplements remains controversial, administration of formulas for 
hepatic failure should be limited to patients with hepatic encephalopathy 
who do not respond to standard treatments. 
Pulmonary Diets 
Patients with pulmonary insufficiency exhibit carbon dioxide 
(CO2) retention and oxygen (O2) depletion. Pulmonary formulas are low 
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in carbohydrates and high in fats (approximately 50% of calories); they 
attempt to decrease respiratory quotient minimize CO2 production and 
retention. It is prudent to avoid carbohydrate overfeeding in patients with 
acute and chronic lung disease until data from clinical trials of adequate 
sample size become available. Critically ill patients who have difficulty 
weaning from ventilators may require a short-term decrease or 
discontinuation of feeding. 
Patient Evaluation Nutritional Assessment 
The main goals of nutritional assessment are (a) to identify patients 
who have, or are at risk for, protein-energy malnutrition or nutrient 
deficiency, and (b) to assess their risks for developing nutrition-related 
complications. 
History and Physical Examination 
The most important parts of nutritional assessment are the patient 
history and physical examination.  
Measurement of body weight and height can be used to compare 
actual and ideal body weight. Body mass index (BMI = weight [kg]/ 
height [m2]) can be used to estimate body fat.  
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Unintentional weight loss greater than 10% within the previous 6 
months indicates malnutrition and is associated with poor clinical 
outcome. 
Biochemical Tests 
Biochemical tests include those for serum albumin, prealbumin, 
retinol-binding protein, transferrin, and creatinine. 
Serum Albumin 
Low serum levels of albumin have been shown to correlate with 
increased morbidity and mortality in hospitalized patients. However, the 
biomarker has relatively poor sensitivity and specificity for protein 
malnutrition, and low levels of serum albumin can be seen in several 
conditions (e.g., inflammatory, gastrointestinal, cardiac, kidney, and liver 
diseases). Plasma albumin is usually unaffected by nutrition intake and 
does not normalize in stressed patients until inflammatory stress is 
resolved. 
Prealbumin and Retinal-Binding Protein 
Prealbumin is a transport protein for thyroid hormones and a 
binding protein for retinol-binding protein.  
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Its half-life is 2 to 3 days. Energy and protein restrictions lower 
prealbumin levels, and refeeding restores them. Infection, liver, and 
kidney failure may affect plasma concentrations of prealbumin. 
Transferrin 
Transferrin has a shorter half-life than albumin, but the serum 
levels depend on a patient's iron store. Transferrin helps identify those 
who are most likely to develop malnutrition and require aggressive and 
closely monitored medical nutrition therapy. 
Creatinine 
Twenty-four hour urinary excretion of creatinine can provide an 
index of lean body mass. Accuracy of the index requires consumption of 
a meat-free diet and effective and complete urine collection. 
Clinical Test 
Subjective Global Assessment 
Subjective global assessment is a clinical method for determining 
nutritional status Patients are categorized as well nourished, moderately 
malnourished, or severely malnourished based on evaluation of weight 
changes, dietary intake, gastrointestinal symptoms, functional capacity, 
and diagnosis. The technique is highly reproducible and is a good 
predictor of medical and surgical complications. 
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Energy Requirements 
Individualized nutritional requirements should be based on current 
and past nutritional state and the nature and complexity of the patient's 
condition. Calories should be adequate to meet basal or resting energy 
expenditures plus energy required for physical activity. Resting energy 
expenditure can be measured using indirect calorimetry or the Harris-
Benedict equation. Indirect calorimetry is considered the “gold standard” 
for estimating resting energy expenditure. However, it is technically 
demanding, time-consuming, involves the use of expensive, specialized 
equipment, and requires trained personnel.  
The use of the Harris-Benedict equation tends to overestimate 
caloric needs. Another equation, the National Academy of Sciences 
equation, also can be employed for predicting the estimated total energy 
expenditure (TEE) of normal and overweight/obese adults (age,>19 
years) and is shown here for men and women. 
Another approach, a computer program, Electronic Parenteral and 
Enteral Nutrition, can provide a rapid definition of the TPN or EN 
prescription for adult and pediatric patients, with reduced likelihood of 
providing excessive glucose and energy. In general, 25 to 30 kcal/kg/d is 
sufficient to meet the energy requirements of most patients. 
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Proteins 
In unstressed adult patients with adequate organ function, protein 
intake of 0.8 g/kg/d is enough to maintain nitrogen balance. However, in 
hypercatabolic patients with acute illness, protein requirements may 
increase to 1.5 to 2 g/kg/d. Protein and non protein energy can be added 
together to calculate caloric requirements 
Carbohydrates 
Carbohydrates are usually the main source of energy. However, 
they can put patients at risk if administered in excess of required needs. 
Excess glucose can promote net de novo lipogenesis, increase carbon 
dioxide production and thermogenesis, cause hepatic steatosis, and 
exacerbate hyperglycemia in glucoseintolerant patients. Patients are 
unable to oxidize more than 5 to 7 mg/kg of body weight per minute of 
intravenously administered glucose. The recommended rate of glucose 
infusion should not exceed 4 to 5 mg/kg/min or 7 g/kg/d. 
Lipids 
When administered with adequate protein, lipids and glucose are 
equally effective at protein sparing. Lipids usually supply 20% to 30% of 
energy requirements. In critically ill, fluid-restricted patients, they 
provide a concentrated source of calories and help avoid complications 
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from carbohydrate overfeeding. Infusion of LCTs at a rate greater than 
0.11 g/kg/h is associated with numerous risks (e.g., impaired immune, 
liver, pulmonary, and platelet functions). 
Lipid administration has been linked to abnormal liver tests, 
cholestasis, and fatty liver. These outcomes raise concerns about the use 
of omega-6–containing vegetable oils as the only source of lipids. 
Patients with gastrointestinal, biliary, or pancreatic disease can have low 
tolerance for enteral LCT. MCTs are more easily absorbed. Use of EN 
formulas with high concentrations of MCTs can help those patients. 
Micronutrients 
Most commercially available enteral formulas are supplemented 
with recommended daily allowances for vitamins (Table 3) and trace 
elements (Table 4). These formulas are usually sufficient for most 
patients fed at levels that meet their caloric needs. 
Some patients, such as those with high losses and severe 
malnutrition, may require extra supplementation. Requirements for 
electrolytes (i.e., sodium, potassium, chloride, bicarbonate, calcium, 
magnesium, and phosphate) depend on baseline levels, calculated losses, 
and maintenance needs.  
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In general, 30 to 40 mL/kg of fluids per day meet the needs of 
most adults. Patients with excess loss from drains, fistulas, or diarrhea 
need extra fluids. 
Monitoring 
Patients receiving EN require careful monitoring. Standardized 
protocols for EN ordering, administration, and monitoring (Table 5) 
should be used. These allow for appropriate estimates of daily nutrient, 
fluid, and electrolyte requirements as well as early detection of toxicity 
and deficiency states, and complications. Daily clinical examinations are 
necessary to identify patients who are intolerant to enteral formulas. 
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Daily Trace Elements 
Trace Element Daily 
Requirement 
Chromium 30 mcg 
Copper 0.9 mg Fluoride 4 mg 
Iodine 150 mcg Iron mg 18 
Manganese 2.3 mg Molybdenum 45 mcg 
Selenium 55 mcg Zinc mg 11 
 
Enteral Access and Insertion/Placement 
Selection of proper enteral access is based on the patient's 
gastrointestinal tract anatomy and function, the anticipated duration of 
feeding, and the potential risk for aspiration. Gastric feeding is the 
preferred approach.  
Gastric access is physiologically accessible, convenient, and makes 
feeding easy to begin. However, it requires intact gag and cough reflexes 
and adequate gastric emptying. 
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Types of Access Nasoenteric 
Nasoenteric, the most commonly used enteral access, is indicated 
for short-term use(<4 weeks). Tubes can be inserted into the stomach, 
duodenum, or jejunum. 
Complications 
Complications associated with nasally inserted tubes include 
nasopharyngeal ulcers, nasal septum necrosis, sinusitis, otitis, hoarseness, 
and vocal cord paralysis. Smallbore feeding tubes made from silicone or 
polyurethane are soft, smooth, and more flexible than stiff, large-bore 
tubes used for decompression and drainage. Small-bore tubes are well 
tolerated for 3 to 4 weeks and they decrease the risk of nasal tissue 
necrosis. 
Small Bowel 
Small bowel access is indicated in patients with conditions 
associated with recurrent aspiration of gastric contents (e.g., severe 
gastroesophageal reflux disease, esophageal dysmotility, gastroparesis, 
and gastric outlet obstruction). It is also indicated when early 
postoperative feeding is planned after major abdominal surgery. 
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Advantages 
In addition to lessening the aspiration risk, postpyloric feeding also 
minimizes the stimulation of pancreatic enzyme secretion. Therefore, it 
can be helpful in critically ill patients with acute pancreatitis and those at 
risk for gastric motility dysfunction. 
Disadvantages 
Major disadvantages of postpyloric feeding include difficult tube 
placement, maintenance of proper positioning, and clogging 
STRESS RESPONSE IN SURGERY 
Humans are highly mobile, active mammals, and as such possess 
metabolic systems that are amazingly adaptable and responsive to the 
demands of physical activity, stress, and injury. Our metabolic machinery 
and capacity have developed to make it possible to both combat 
infectious disease and recover from injury. However well adapted we are 
in dealing with infection and injury, these insults have the potential to 
demand an extreme workload from the body, and thus can push 
metabolic responses to a point of dysfunction or failure. Although one 
can conceptualize the processes of metabolism with relatively simple 
and familiar equations involving the “burning” of sugar or fat to produce 
adenosine triphosphate (ATP), the  causes of metabolic dysfunction go 
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beyond biochemical reactions, and are complex at both the cellular and 
organ/system levels. In terms of management of patients with trauma and 
infection, the balance between homeostasis and crisis can shift rapidly, 
and thus it behooves the attending surgeon to closely monitor and 
preserve the patient's metabolic capacity to make possible recovery or 
even survival. 
Mitochondria: The Center of Metabolism 
Although metabolic dysfunction from trauma and infection affects 
critical organ systems in a variety of ways, its genesis generally is linked 
to a single organelle, the mitochondrion. Mitochondria are commonly 
referred to as the “powerhouse of the cell.” The power is distributed via 
the high-energy phosphate bonds of ATP. This energy resides in the 
terminal phosphate of ATP. When this bond (i.e., that between the 
second and third phosphates) is cleaved, it releases a substantial amount 
of energy (~7 kcal/mol ATP). ATP is thus a safe and stable fuel, which 
contains a large amount of energy that may be used to facilitate a wide 
variety of biologic processes. Among these are the powering of enzymes 
that make or break chemical bonds, muscle contractions, phosphorylation 
of signaling proteins, ion pumps, and active transport activities. The 
conversion of substrates (glucose, ketones, fatty acids, lactate, etc.) to 
ATP is accomplished via a highly efficient process that uses oxygen. For 
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example, oxidation in the Krebs citric acid cycle of one molecule of 
glucose has the potential to yield >30 molecules of ATP. This remarkable 
efficiency derives from the close physical and biochemical coupling of a 
series of enzymes situated along the inner membrane of the 
mitochondrion. This chain of enzymes is more complex than the 
nomenclature suggests, being comprised of >80 peptides. They and their 
substrates are shown in a schematic form in Figure 1. Complexes I, III, 
and IV are proton (H+) pumps, which are engaged in creating an 
electrochemical gradient, whereas complex V utilizes the H+ to add the 
terminal high-energy phosphate to the adenosine diphosphate (ADP) 
donor. Complex VI likewise consumes H+, functioning to uncouple 
electron transport for thermogenesis, and can also protect the 
mitochondrion by diverting electrons to the inner membrane. Although it 
is extremely efficient, the process is not absolutely perfect, and the 
features shown in gray have the capacity to “leak” electrons. As a 
consequence, these free electrons can generate reactive oxygen, which 
has great importance in the pathophysiology of infection and trauma 
.Mitochondria can increase the output of ATP in response to a variety of 
triggering events.These include accumulation of ADP or the greater 
availability of “fuel” and oxygen. Cellstimulatory signals, such as the 
presence of increased Ca2+ in the cytoplasm, also stimulate the 
mitochondria to generate more ATP. These stimuli are tied to an 
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increased demand for work from the body, be it muscular (heart or 
skeletal muscle contraction), biosynthesis (production of proteins by the 
liver), cell division (immune responses or tissue repair), or the generation 
of heat (response to hypothermia). Clearly, all of these functions can be 
tied to the demands of dealing with infection and injury. 
Mitochondrial Dysfunction 
The failure of mitochondrial energy production lies not with the 
organelle itself, but with its various “supplies.” The situation is analogous 
to that seen in a manufacturing plant that uses the Japanese-style just-in-
time inventory strategy. In this example, under ordinary manufacturing 
conditions, the various components come together from outside shippers 
in a timely fashion, and the products roll off the assembly line, with a 
minimum drain on operating capital. However, the vulnerability of this 
strategy becomes apparent when any critical components come into short 
supply; production abruptly ceases, and the entire plant must shut down. 
This analogy holds with the mitochondrion, owing to a curious fact in the 
nature of ATP production.  
Unlike sugars or fats, which are stored as glycogen or adipose 
tissue, respectively, there are no depot stores of ATP. Thus, with a failure 
to deliver any of the essential components (cardiac output and/or blood 
flow, lung oxygenation, glucose transport, etc.), there is a rapid onset of 
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metabolic dysfunction. At the level of the mitochondrion, this 
dysfunction has many forms. 
One failure of the mitochondrion with immediate biochemical 
consequences is the production of reactive oxygen species (ROS). These 
products take numerous forms, such as superoxide, peroxides, nitric 
oxide, and peroxynitrite. Because ROS are constitutively produced by 
mitochondria, there are neutralizing compounds (antioxidants) such as 
glutathione that buffer against the damage of ROS. An additional 
consequence of mitochondrial dysfunction is spillage of the contents of 
the mitochondrion into the cell's cytoplasm. This occurs through 
“permeability transition pores,” which open in a fission response to 
stress, and provide a channel for substances such as cytochrome c to 
enter the cytoplasm and trigger programmed cell death 
(apoptosis). These events are depicted schematically 
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Mitochondrial Metabolism in Infection and Injury 
The effects of infection on metabolism have been extensively 
studied, and will be covered in detail later in this chapter. However, there 
are some generalities that are specific to mitochondria with reference to 
sepsis and injury, and how they are studied. At the outset it should be 
stated that the experimental literature is somewhat confusing, largely 
because of the varied animal models and experimental designs that have 
been brought to bear on the problem.  
Thus, although a model may focus on a single variable to dissect 
one component of infection away from “noise,” this compromise itself 
may fail to replicate what a physician sees at the bedside. A good 
example of this is found in experimental sepsis, which can range from 
injection of a single pure strain of microbe, to polymicrobial sepsis using 
the animal's own gut flora, to those involving no living organisms but 
instead their metabolites or cellular components. A common example of 
the latter is the infusion of lipopolysaccharide (LPS, also known as 
endotoxin).  
Although it may seem meaningless to employ a model devoid of 
living organisms, it has been observed that LPS alone can trigger severe 
metabolic dysfunction at higher doses. This is because the effects of LPS 
are amplified through interaction with specific receptors that trigger a 
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cascade of responses (cytokine secretion, gene transcription, apoptosis, 
etc.). Thus, in light of the variety of laboratory conditions used to model 
sepsis, it is not surprising that experimental sepsis has shown a range of 
mitochondrial damage, from none to mild to severe. 
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There are some common features of sepsis vis-à-vis mitochondria, 
however. Under conditions of sepsis, and especially septic shock, there 
will very likely be severe morphologic damage to the mitochondria. Also, 
ATP levels will decline, as observed clinically and with experimental 
sepsis. ROS will also increase to harmful levels, exhausting the reserve 
of antioxidants.  
ROS can damage not only the mitochondrion itself, but other 
organelles and molecules within the cell, including DNA. These events 
all become more likely to occur with a longer duration of infection, 
which allows for microbial growth and expansion, toxin accumulation, 
and increased workload energy demands. Not unexpectedly, the 
likelihood of multiple organ systems being affected by sepsis also 
increases with time. There may be serious impairment of vital (renal, 
hepatic, lung, cardiac) and nonvital (skeletal muscle) organ function.  
These failures are exacerbated by persistent hypotension, even in 
the face of more than adequate volume resuscitation. In most cases these 
tissues exhibit a loss of mitochondrial function. There will also be a fall 
in cellular/tissue ATP levels, matched by a rise in ADP and adenosine 
monophosphate (AMP). A final apparent self-preservation response is 
often seen in advanced sepsis (marked by widespread organ failure and 
systemic inflammation)—namely, a broad shutdown of energy 
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consumption, not unlike a hibernation response. Taking these facts 
together, it is not hard to understand why the syndrome of multiorgan 
dysfunction or failure is a common cause of death among critically ill 
patients. 
Although injuries vary greatly, serious injuries have common 
features that can unfavorably affect mitochondrial metabolism. 
Hemorrhage effectively produces hypoxia, which initiates a cascade of 
responses that are directed toward adaptation to lowered oxygen, which 
can at the same time be damaging to an already injured body. Hypoxia 
and ischemia-reperfusion, with their lowered oxygen availability to the 
tissues, will drive the cells to depend on anaerobic glycolysis for their 
high-energy phosphate production. This can initiate a feedback situation, 
wherein lactic acid increases, effectively shutting down anaerobic 
glycolysis as an energy source. In this setting, free fatty acids can also 
increase systemically, probably from peripheral adrenergic stimulation of 
lipolysis. Limited oxygen also compromises β-oxidation, the principal 
means of converting fats to energy. 
This in turn causes a similar “stacking up” of free fatty acids, acyl 
coenzyme A (acyl CoA), acylcarnitines, and so on, which compromises 
the heart. Under these conditions the heart and other tissues are already at 
a disadvantage because, despite the high energy stored in fat, β-oxidation 
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cannot match the efficiency of carbohydrate metabolism. Thus, 
reoxygenation, if it occurs, may take place in a setting in which aerobic 
metabolism is not possible, because of large-scale diversion of 
metabolism into the less efficient “backup” modes of β-oxidation and 
anaerobic glycolysis.  
There is one additional consequence of elevated lactic acid worth 
noting. As mentioned previously, an intracellular flux of calcium will 
cause a demand for increased ATP synthesis.  
The presence of increased lactic acid in the cell will cause calcium 
to enter the cytoplasm from the exterior, providing a spurious signal for 
increased workload at a time when the metabolic machinery is incapable 
of reacting appropriately.  
This has the untoward effect of further depleting already low 
supplies of ATP. Finally, regarding the lowered ATP supplies, an 
obvious solution for treatment would be to administer agents/drugs that 
increase ATP production under low-flow conditions. However, such 
agents will not be effective if the microcirculation is markedly impaired 
prior to their administration. 
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Trauma, Infection, and Metabolism as Related to Medicine 
Trauma and infection initiate changes in metabolism that can affect 
virtually all organs and tissues, by altering carbohydrate, lipid, and 
protein metabolism. The metabolic response to injury and sepsis has 
traditionally been divided into an ebb phase and a flow phase followed 
by a convalescence phase.  
This metabolic pattern is better defined after injury than during 
sepsis. The metabolic course during sepsis is more convoluted because 
the septic insult is usually more insidious in its onset and can vary in its 
duration and intensity. Individuals with severe sepsis or septic shock 
display many of the characteristics of the ebb phase, whereas patients 
with a more chronic, less severe sepsis display the hypermetabolism and 
catabolism of the flow phase (“hypermetabolic sepsis”). The ebb phase is 
dominated by glycogenolysis and lipolysis, which provides the organism 
with energy substrates for “fight or flight” responses.  
This is followed by the flow phase, a state of catabolism 
manifested by elevated metabolic rate and increases in body temperature, 
pulse rate, urinary nitrogen excretion, and muscle catabolism. The 
subsequent anabolic “recovery” phase can last from weeks to months. 
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This section describes, at the tissue and cellular levels, the 
characteristic changes in carbohydrate, lipid, and protein metabolism that 
occur in trauma and sepsis, and discusses mediators, including hormones 
and cytokines, that regulate the metabolic changes. In addition, 
intracellular mechanisms and molecular regulation of metabolic 
consequences of injury and severe infection are discussed. 
Understanding the metabolic response to injury and sepsis is 
important from  a clinical perspective for several reasons. Some of the 
metabolic alterations that occur after injury and severe infection are 
essential for survival.  
For example, several studies have found a correlation between 
survival and maintenance of the acute-phase response in the liver. In 
contrast, the excessive muscle catabolism that occurs during sepsis may 
be detrimental to patients, delaying recovery, slowing ambulation, and 
increasing the risk of pulmonary complications if the respiratory muscles 
undergo proteolysis.  
Identifying methods to limit excessive catabolism may therefore be 
advantageous. By understanding the mediators and mechanisms of the 
physiologic and metabolic response to trauma and infection, one may 
develop novel therapeutic strategies to target specific metabolic 
alterations, which may possibly lead to improved survival. 
40 
 
Metabolic Mediators 
Many of the metabolic alterations that occur in response to trauma 
and infection are regulated by hormones and cytokines. Frequently, these 
substances interact with each other to induce a complete metabolic 
response. Before the role of these mediators in the regulation of 
metabolism is discussed, the influence of injury and sepsis on their 
release is reviewed. Although a number of other biologically active 
substances are released after injury and sepsis, such as nitric oxide (NO), 
oxygen radicals, prostaglandins, leukotrienes, and complement 
components, this section focuses on hormones and cytokines because 
they have been studied extensively as regulators of metabolism. Whereas 
classically the counterregulatory hypothalmic-sympathoadrenal pathway 
has been regarded as separate from the cytokine cascade, in fact they are 
related and interact (Fig. 3).  
Hormones the classification of hormones can be based on different 
properties. For example, hormones can be classified as being regulated at 
the level of the hypothalamus (e.g., corticotropin releasing hormone, 
thyrotropin-releasing hormone), pituitary gland (adrenocorticotropic 
hormone, thyroid-stimulating hormone), or autonomic nervous system 
(epinephrine, norepinephrine). 
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Another classification is based on the chemical properties and 
divides hormones into polypeptides (e.g., insulin, glucagon), amino acid 
derivatives (e.g., thyroxine, epinephrine, norepinephrine), and fatty acid 
derivatives, originating either from cholesterol (e.g., glucocorticoids) or 
arachidonic acid (prostaglandins, leukotrienes). 
Hormones can also be classified based on binding to intracellular 
receptors (e.g., glucocorticoids, thyroid hormones) or cell membrane 
receptors.  Binding of hormones to cell membrane receptors, in turn, can 
influence cell metabolism through activation of different second 
messengers, including cAMP (e.g., catecholamines, glucagons), cGMP 
(e.g.,atrial natriuretic peptide), calcium and phosphatidylinositides (e.g., 
epidermal growth factor), and kinase/phosphatase cascades (e.g., insulin, 
IGF-I).  
Cell membrane receptors can be divided into receptor kinases, G-
protein-coupled receptors, and ligand-gated ion channels. From a 
metabolic standpoint, hormones can also be divided into anabolic and 
catabolic (counter regulatory) hormones. Injury and sepsis are associated 
with a pronounced neuroendocrine response with an initial 
sympathoadrenal discharge, which stimulates the release of the counter 
regulatory hormones glucagon, epinephrine, norepinephrine, growth 
hormone (GH), and cortisol. The stimuli that activate the neuroendocrine 
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response during trauma and infection include hemodynamic changes 
(caused by hemorrhage, dehydration, third space losses, etc.), changes in 
pH, pO2, pCO2, ambient or body temperature, substrate availability (e.g., 
plasma glucose and amino acids), pain, and anxiety. 
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The counterregulatory hormones respond to hypoglycemia and 
play a role in glucose “counterregulation.” Several of the 
counterregulatory hormones have a catabolic effect and are called 
catabolic hormones.  
The counterregulatory hormones are usually elevated during the 
ebb phase after injury but can remain increased into the flow phase 
during sustained injury, such as burn injury, and during sepsis. Numerous 
reports are found in the literature of increased levels of cortisol, 
glucagon, catecholamines, and GH after trauma, burn injury, infection, 
and sepsis. From a metabolic standpoint, cortisol is probably the most 
important among the counterregulatory hormones, with widespread 
effects on glucose, amino acid, and fatty acid metabolism. The release of 
glucocorticoids in trauma and sepsis is centrally regulated. Thus, stress 
results in hypothalamic release of corticotropin-releasing factor, which in 
turn stimulates pituitary release of adrenocorticotropic hormone (ACTH). 
ACTH regulates cortisol synthesis and release from the adrenal cortex. 
The importance of the role of the central nervous system during 
trauma and infection is illustrated by the fact that the glucocorticoid 
response can be abolished by blocking afferent nervous stimuli. Studies 
suggest a role for endogenous opiates and opioids as contributing 
mediators in the neuroendocrine response. Central nervous system 
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hypoglycemia during the early part of the ebb phase likely causes 
increased release of central nervous system morphine. The elevated 
morphine levels may play a role in mediating metabolic alterations, 
including intestinal proteolysis. 
In addition to the catabolic hormones, trauma and infection 
influence other hormones as well most notably insulin, insulin-like 
growth factor I (IGF-I), and thyroid hormone. Plasma insulin levels 
decrease during the ebb phase and rise during the catabolic flow phase. 
Although levels of plasma insulin are high during the flow phase, plasma 
glucose levels remain elevated, a finding that supports the concept of 
“insulin resistance” in peripheral tissues, in particular in skeletal muscle, 
during sepsis and after trauma. Evidence suggests that the insulin 
resistance in these conditions is at the postreceptor level and may be 
mediated by β-adrenergic receptor activity and tumor necrosis factor-
alpha (TNF-α). 
Circulating IGF-I levels decrease in critically ill patients and in 
patients with sepsis. IGF-I and insulin are anabolic hormones that 
promote protein and glycogen synthesis and block protein breakdown. 
Reduced levels of the anabolic hormones, in addition to increased levels 
of the catabolic hormones, may represent an important mechanism by 
which metabolic alterations occur during trauma and infection. Not only 
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is there a reduction in IGF-I levels, peripheral tissues become resistant to 
IGF-I in various catabolic conditions, including sepsis. Both IGF-I and 
insulin have been used as therapeutic agents in an effort to reduce post 
injury catabolism. One reason this treatment has not always been 
successful is probably the development of hormone resistance. 
Gender Differences in Injury Response 
Hormones, especially sex steroids, have been found to play a 
highly significant role in the response to injury, in addition to their role in 
modulating metabolism. Principal among these observations is that high 
estrogen levels have a protective effect against injuries, such as shock, 
trauma hemorrhage, and sepsis, insofar as protecting from immune and 
cardiovascular depression.  
This finding stemmed from the observation that proestrus females, 
but not postestrus females or male mice, were resistant to sepsis induced 
by cecal ligation and puncture. Moreover, proestrus females also 
showed maintained or enhanced immune as well as cardiovascular 
responses as opposed to decreased responses in postestrus females and 
males following trauma hemorrhage. Further investigation confirmed 
these observations, and led to the finding that administration of 
exogenous estrogen (i.e., to males, or females with low/no estrogen) 
following trauma hemorrhage was capable of replicating the protective 
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effect of high levels of endogenous hormone. For androgens, the 
converse appears to be true, in that blockade of androgen receptors with 
antagonists such as flutamide improves performance and outcomes for 
males.  
These findings with estrogen (E2) have been extended to other 
steroid intermediates of estrogen biosynthesis (DHEA, adiol) and 
nonsteroid peptide hormones (prolactin). Blockade of the estrogen 
receptor with estrogen mimetic antagonists (ICI 182,780) results in a loss 
of estrogen protection, demonstrating that the effects are receptor 
mediated. Thus, the systemic and functional level of hormones may have 
implications for injury outcomes from either an epidemiologic or 
therapeutic standpoint. Although these gender effects are secondary to 
the direct ability of hormones to alter metabolism, it is clear that they 
have significant influence on injury and infection, and thus will likewise 
affect the metabolic status of the host. 
Metabolic Responses to Injury and Infection 
Trauma and sepsis induce substantial changes in carbohydrate, 
lipid, and protein metabolism in most organs and tissues. In addition, 
important  changes in fluid balance, electrolytes, acid–base balance, and 
tissue oxygenation occurCarbohydrate Metabolism Early in the course of 
sepsis and endotoxemia, serum glucose levels rise, mainly reflecting 
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increased hepatic glucose production caused by stimulated 
glycogenolysis and gluconeogenesis. Concomitant with the increased 
hepatic glucose production is increased glucose utilization in multiple 
tissues, including liver, spleen, small intestine, skin, and some (but not 
all) muscles. A common feature of some of these tissues is a high content 
of macrophages.  
Studies have shown that, in the liver, the high glucose uptake 
reflects increased utilization of glucose by Kupffer cells. In addition, 
endotoxemia is associated with a substantial inflow of neutrophils into 
the liver, and these cells also contribute to the increase in glucose uptake. 
Interestingly, the hepatocyte uptake of glucose does not change, which 
suggests a dichotomy in glucose kinetics between hepatocytes and 
Kupffer cells during sepsis and endotoxemia. Because the rate of 
glucose production exceeds the rate of glucose disposal during this phase 
of sepsis and endotoxemia, serum glucose levels are elevated. 
Another factor contributing to increased serum glucose is the 
insulin resistance in muscle and fat, which results in a relative inhibition 
of glucose uptake by these tissues. If sepsis is prolonged, hypoglycemia 
usually  develops as hepatic glucose production fails. Hepatic glycogen is 
depleted during protracted sepsis, and the liver has to rely on 
gluconeogenesis for glucose production. In late sepsis, gluconeogenesis 
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may be inhibited secondary to decreased supply of gluconeogenic 
substrates and altered enzyme function. 
Some studies suggest that decreased phosphoenol pyruvate 
carboxykinase activity is a mechanism of reduced hepatic 
gluconeogenesis, whereas other reports have implicated stimulated 
phosphofructokinase 1 activity. 
Despite decreased glucose production and hypoglycemia in 
prolonged and severe sepsis, uptake remains high in macrophage-rich 
tissues, which further exacerbates hypoglycemia. This in turn may 
contribute to mortality during septic shock. 
Regulation of Carbohydrate Metabolism during Trauma and 
Infection 
This section focuses on the role of hormones and cytokines and 
their interaction in the regulation of metabolism after trauma and 
infection. Other factors also participate in the regulation of metabolism 
during infection and injury, including NO and prostaglandins. The 
hormones involved in the regulation of carbohydrate metabolism during 
trauma and infection include the counterregulatory hormones and insulin.  
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In this respect, catecholamines and glucagon are the major 
counterregulatory hormones in humans. Evidence in support of the role 
of the counterregulatory hormones was found in experiments in which 
intravenous infusion of a combination of glucagon, epinephrine, and 
cortisol (“triple hormone infusion”) resulted in alterations in whole-body 
carbohydrate metabolism similar to those seen in sepsis and other critical 
illness. Regulation of carbohydrate metabolism by catecholamines is well 
recognized.  
Epinephrine influences carbohydrate metabolism by increasing 
hepatic glycogenolysis, followed by stimulated gluconeogenesis, and by 
inhibiting the metabolic clearance rate of glucose, which further increases 
serum glucose levels. In addition, epinephrine stimulates release of 
glucagon and inhibits release of insulin, further contributing to 
hyperglycemia. In burned patients, treatment with phentolamine and 
propranolol reduced whole-body metabolic rate, the role of 
catecholamines in the regulation of metabolism after injury.  
Glucagon plays a more important role in the control of 
carbohydrate metabolism during sepsis, at least in the regulation of 
hepatic glucose production.  
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The important role of hyperglucagonemia seen during sepsis was 
demonstrated in experiments in which the hormone was blocked by 
infusion of somatostatin in septic rats and the elevated rate of glucose 
production was reduced to control levels. In contrast, treatment with 
somatostatin did not decrease sepsis-induced increase in glucose 
disposal, which suggests that the two aspects of carbohydrate metabolism 
(hepatic glucose production and glucose clearance) are controlled by 
different mechanisms during sepsis. Glucagon probably does not act 
alone during sepsis but instead acts synergistically with other mediators, 
such as glucocorticoids and catecholamines. 
Insulin also plays a key role in the regulation of carbohydrate 
metabolism in injury and sepsis. Insulin levels vary depending on the 
phase of injury. During the ebb phase, insulin levels are reduced despite 
hyperglycemia. The combined effects of catecholamines, somatostatin, 
glucocorticoids, and reduced pancreatic blood flow may reduce 
pancreatic β- cell sensitivity to glucose. During the flow phase, β cells 
regain their sensitivity and insulin concentrations rise. Despite increased 
insulin concentrations, however, hyperglycemia may persist, consistent 
with peripheral insulin resistance. Clinically, the presence of insulin 
resistance is evident from reduced hormone response when exogenous 
insulin is administered to septic or injured patients. The insulin resistance 
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is secondary to a postreceptor alteration resulting in decreased cellular 
responsiveness to insulin, possibly mediated by TNF and catecholamines. 
In addition to hormones, cytokines also regulate carbohydrate 
metabolism. The most extensively studied cytokine in terms of regulation 
of carbohydrate metabolism is TNF. Changes in glucose metabolism 
during endotoxemia and sepsis can be reproduced by the in vivo 
administration of TNF with increased hepatic production of glucose, 
hyperglycemia, and stimulated glucose utilization by macrophage-rich 
tissues and diaphragm. The effect of TNF on glucose kinetics is dose 
dependent, with relatively modest doses causing hyperglycemia and 
larger doses inducing hypoglycemia.  
The hypoglycemia seen after high doses of TNF can be explained 
at least in part by increased peripheral glucose utilization, although 
impaired hepatic gluconeogenesis may contribute. The data from in vivo 
studies do not define whether TNF has a direct or indirect effect on 
hepatic glucose metabolism. Administration of TNF induces a stress 
response, and the effects of TNF may be secondary to release of 
counterregulatory hormones. Indeed, infusion of phentolamine and 
propranolol prevented the increase in glucose appearance noted in rats 
treated with TNF, a finding which suggests that the TNF-induced 
increase in hepatic glucose production may be indirect and at least in part 
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mediated by catecholamines. This observation provides an additional 
example of interaction between cytokines and hormones. Because 
pretreatment of septic or endotoxemic rats with anti-TNF antibodies did 
not modify the changes in whole-body carbohydrate metabolism as 
assessed from measurements of plasma glucose and lactate levels and 
rates of glucose appearance and clearance, endogenous production of 
TNF probably is not a requirement for the increase in hepatic glucose 
production and whole-body glucose disposal seen in endotoxemia and 
hypermetabolic sepsis. Unlike in the liver, TNF may have a direct effect 
on cellular glucose kinetics in muscle and adipose tissue.  
Exposure of cultured adipocytes to TNF resulted in a dose- and 
time dependent increase in glucose transport, measured as uptake of 2-
deoxyglucose. The molecular regulation of the TNF-induced glucose 
transport was multifaceted; TNF caused  an initial translocation of the 
glucose transporter to the cell surface, followed by an increased 
transcription rate of the glucose transporter gene , stabilization of glucose 
transporter mRNA, and increased production of the glucose transporter 
protein. In addition to TNF, IL-1 also can influence carbohydrate 
metabolism. For example, previous experimental work demonstrated that 
plasma glucose levels decreased after administration of IL-1 to rats. 
When equal doses of IL-1 were injected intracerebroventricularly and 
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intraperitoneally, only animals receiving the IL-1 
intracerebroventricularly demonstrated hypoglycemia, suggesting that IL-
1 exerts its effect on carbohydrate metabolism through the central 
nervous system. 
Decreased hepatic glucose production and increased peripheral 
glucose transport and utilization are mechanisms by which IL-1 may 
induce hypoglycemia. Lipid Metabolism Circulating levels of free fatty 
acids, triglycerides, and cholesterol are increased during injury and 
sepsis. 
 The mechanism of these changes is multifactorial, with stimulated 
synthesis in the liver of apolipoproteins and triglycerides being the major 
mechanism of hypertriglyceridemia. Contributing factors include reduced 
activity of the enzyme lipoprotein lipase in muscle and adipose tissue, 
which decreases the clearance of triglyceride-rich lipoproteins, and 
increased lipolysis in adipose tissue. Although the fact that hepatic 
synthesis of triglycerides increases during sepsis is fairly well accepted, 
the influence of sepsis and endotoxemia on the secretion of triglycerides 
is more controversial, with studies showing both unchanged and reduced 
secretion. Although plasma levels of free fatty acids and triglycerides are 
usually elevated during sepsis and endotoxemia, this is not always the 
case. One reason for this may be decreased perfusion of adipose tissue 
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during severe sepsis or endotoxic shock, which results in reduced 
lipolysis and decreased plasma levels of free fatty acids. Fatty acids are 
also used as an alternative energy source by peripheral tissues after injury 
and sepsis, and if the rate of fatty acid clearance (peripheral oxidation) is 
higher than the rate of appearance (lipolysis) or production (hepatic 
lipogenesis), plasma fatty acid concentrations do not increase. Alterations 
in lipid metabolism as manifested by increased lipolysis and stimulated 
hepatic production of triglycerides and fatty acids are beneficial to the 
injured and septic organism for several reasons.  
Because lipid substrates are provided as an alternative energy 
source for peripheral tissues, including muscle and the immune system, 
glucose is spared for the nervous system. In addition, lipoproteins can 
bind endotoxin and a number of different viruses. Increase in plasma 
lipoproteins may therefore help protect the organism from the toxic and 
lethal effects of endotoxin and infectious agents. 
Regulation of Lipid Metabolism 
Hormones regulate lipid metabolism in both adipose and other 
tissues. The role of hormonal control of lipid metabolism in injury and 
infection, however, is probably less prominent than that of other 
mediators, such as cytokines. An exception to this may be the 
catecholamines. For example, the sepsis-induced increase in palmitate 
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appearance can be inhibited by combined α- and β-adrenergic blockade. 
This is consistent with other reports that catecholamines stimulate 
lipolysis in adipose tissue, producing, in part, the “posttraumatic 
lipemia.”  
There is evidence that cytokines may participate in the regulation 
of lipid metabolism after injury and infection. TNF has received most 
attention in this respect, in part because of work done in the 
characterization of the cause of cancer cachexia. In early studies, a factor, 
then called cachectin, was identified from the serum of patients with 
cancer and shown to be an inducer of both the cachexia and 
hyperlipidemia that accompany some tumors. Subsequent studies showed 
that cachectin and TNF are the same substance. TNF infusion in vivo 
causes several changes in lipid metabolism that are similar to those that 
occur during sepsis and injury.  
One mechanism by which TNF may alter lipid metabolism is 
reduction of lipoprotein lipase activity, so that degradation of lipoproteins 
is decreased. This regulation probably occurs at the molecular level by 
downregulated lipoprotein lipase gene expression in adipose tissue. 
Downregulation of lipoprotein lipase, however, may not be the only 
mechanism by which TNF induces hypertriglyceridemia, because in 
some studies, serum levels of triglycerides were increased before a 
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decreased lipoprotein lipase activity could be detected in adipose tissue 
after administration of TNF. 
The liver is probably the major site at which TNF influences lipid 
metabolism. Evidence exists that TNF stimulates both synthesis and 
secretion of triglycerides in the liver. Fatty acids are the rate-limiting 
substrates in triglyceride synthesis. TNF treatment does not change 
activities of the enzymes involved in the esterification of fatty acids to 
glycerol, which suggests that the stimulated triglyceride production in the 
liver is due primarily to availability of fatty acids. 
In addition to stimulated liver synthesis of fatty acids, increased 
lipolysis in adipose tissue can also increase fatty acid availability. TNF 
stimulates both these processes. Interestingly, the effect of TNF on fatty 
acid synthesis is site specific. Thus, whereas TNF increases fatty acid 
synthesis in the liver, it does not influence this process in muscle, fat 
tissue, or small intestine.  
The mechanism for this differential effect is not clear but may 
reflect differences between tissues in the activity of enzymes responsible 
for fatty acid synthesis. Other factors may contribute to the ability of 
TNF to alter lipid metabolism. For example, catecholamines and TNF act 
synergistically to increase lipolysis. Nutritional status may also be 
important in TNF-induced hypertriglyceridemia. In chow-fed rats, 
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lipolysis in adipose tissue was stimulated after TNF administration, 
increasing the availability of fatty acids. In contrast, in sucrose-fed rats, 
TNF markedly stimulated hepatic de novo synthesis of fatty acids. Both 
conditions resulted in increased triglyceride production by the liver. The 
observation that TNF can stimulate hepatic triglyceride synthesis and 
increase plasma triglyceride levels through multiple mechanisms 
supports the concept that changes in lipid metabolism play an important 
role in the overall response to infection and inflammation.  
Although the role of TNF has been studied most extensively in the 
regulation of lipid metabolism, other cytokines as well may influence 
lipid metabolism, including IL-1, interferon-α (IFN-α), interferon-β (IFN-
β), and IFN–γ. 
The mechanism by which different cytokines alter fatty acid 
synthesis may vary. For example, citrate levels increase after TNF, IL-1, 
and IL- 6 treatment of adipocytes in culture. Citrate is an activator of 
acetyl coenzyme-A carboxylase, the rate-limiting enzyme in fatty acid 
synthesis. IFN-α treatment does not increase citrate levels, which 
suggests an alternative mechanism. These different mechanisms may 
explain the results of simultaneous cytokine treatment. Thus, 
administration of IFN-α and either TNF or IL- 1 resulted in an additive 
effect on fatty acid synthesis. In contrast, maximal doses of TNF and IL-
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1 given together (presumably working through the same mechanism) did 
not further increase fatty acid synthesis. Not all cytokines stimulate fatty 
acid synthesis.  
Studies suggest that IL-4 inhibits hepatic fatty acid synthesis 
induced by TNF, IL-1, or IL-6. IL-4 alone had no effect and did not 
influence the stimulated hepatic fatty acid synthesis stimulated by IFN-α. 
These results are further support of the concept that different cytokines 
induce hepatic lipogenesis through distinct mechanisms. 
Protein Metabolism 
Among the metabolic alterations that occur after injury and 
infection, those affecting protein metabolism have been studied 
extensively.  
This section of the chapter focuses on changes in protein 
metabolism in skeletal muscle, liver, and intestine and argues for the 
concept that these changes are part of an integrated metabolic response to 
injury and sepsis. 
Muscle 
Interest in protein metabolism after trauma began when studies by 
Sir David Cuthbertson more than 70 years ago demonstrated increased  
urinary excretion of nitrogen, phosphate, and sulfate in patients with 
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long-bone fractures. A number of subsequent studies provided evidence 
that skeletal muscle is the major source of increased urinary nitrogen 
secretion after injury and sepsis. Negative nitrogen balance and muscle 
catabolism are well-recognized metabolic responses to these conditions. 
The catabolic condition in muscle that develops during critical illness is 
multifactorial and is caused by a combination of reduced protein 
syntheses, increased protein breakdown, and inhibited amino acid uptake. 
From a quantitative standpoint, the increase in protein breakdown, in 
particular the breakdown of the myofibrillar proteins actin and myosin, is 
the most prominent component of muscle catabolism after injury and 
sepsis.  
Increased myofibrillar protein breakdown results in increased 
urinary excretion of 3- methylhistidine in injured and septic patients and 
increased release of 3-methylhistidine by incubated muscles from septic 
animals.  
 The breakdown of myofibrillar proteins may in part explain the 
muscle weakness typically seen in patients with severe trauma and sepsis 
and may severely impair recovery in these patients.  
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The net result of decreased protein synthesis and increased protein 
breakdown is the release of amino acids from muscle, in particular 
glutamine. Inhibited cellular uptake of amino acids contributes to the 
peripheral release of amino acids in injury and sepsis. As no storage 
protein per se exists, skeletal muscle may be viewed as an endogenous 
source of amino acids for the rest of the body during infection and injury, 
which is of particular importance for protein synthesis and function in 
liver, intestine, and cells of the immune system. 
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METHODOLOGY 
 
 DESIGN OF STUDY : Prospective Study 
 PERIOD OF STUDY : 1 Year (October 2016 - September 2017) 
 COLLABORATING DEPARTMENT : None 
 SELECTION OF STUDY SUBJECTS :all patient satisfying 
inclusion criteriaadmitted in govt rajaji hospital for a period of 1 year 
 
INCLUSION CRITERIA 
All Patients undergoing emergency gastrointestinal surgeries in 
acute abdomen within 24 hours. 
 
EXCLUSION CRITERIA 
 Patients with severe shock. 
 Patients managed in ICU for more than 2 days postoperatively 
 Patients requiring bowel resection and anastomosis . 
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METHOD OF COLLECTING DATA 
 All patients in general surgical ward undergoing emergency 
gastrointestinal surgeries in acute abdomen within 24 hours under 
critertia will be subjected to 2 groups. Group 1 getting early enteral 
feeding(E group) by oral or nasogastric 24 to 48 hrs after surgery(POD -
2) and group 2 getting late enteral feeding(L group)(more than 48 hrs). 
After that patients are followed up closely for various complication 
namely wound infections, pulmonary complications and post op ileus 
along with duration of hospital stay. 
FEEDING MATERIALS GIVEN 
 Tender coconut water/fruit juices(carbohydrate drinks)+protein 
powder solution in 2:1 ratio. Patients were started on 500mL of above 
mentioned feed within the first 48 hours and the feeds increased by 
500mL incrementally  on each consecutive post operative day.  
CONSENT  :  Individual written and Informed consent  
ANALYSIS  :  Statistical Analysis using SPSS software 
CONFLICT OF INTEREST : None 
FINANCIAL SUPPORT : Nil From The Institution 
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OBSERVATIONS AND RESULTS 
The cases were studied from a period of October 2016 to 
September 2017. Total of 60 cases were studied and analysed. 
GENDER DISTRIBUTION 
A total pf 30 cases and 30 controls were studied. The gender 
distribution among cases and controls were demonstrated to be according 
to the table below. 
SEX CASE CONTROL 
Male 18 23 
Female 12 7 
Total 30 30 
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CASE DISTRIBUTION 
Among the cases admitted and underwent emergency laparotomy, 
most common case operated was early duodenal perforation. 
DIAGNOSIS CASES CONTROL 
SIGMOID VOLVULUS 2 2 
EARLY DUODENAL PERFORATION 12 12 
SUB ACUTE INTESTINAL OBSTRUCTION 12 10 
LARGE BOWEL GROWTH 4 6 
TOTAL 30 30 
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COMPLICATIONS 
The case were followed up and the complications were recorded in 
both groups. 
 
A. WOUND INFECTIONS 
In case group 3 patients developed wound infection with discharge 
(2 case on POD 3 and one case on POD 5) of which 2 case developed 
wound gaping and needed secondary suturing 
In control group 9 patients developed wound infection with 
discharge (3 case on POD 2 and 3 case on POD 3) Another 3 cases 
developed wound gaping and needed secondary suturing. 
The rates of wound infections were significantly lower in the case 
group when compared to the control group (p=0.0213) 
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WOUND INFECTION CASE CONTROL 
YES 3 9 
NO 27 21 
Total 30 30 
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B. POST OPERATIVE ILEUS 
POST OP ILEUS CASE CONTROL 
YES 3 9 
NO 27 21 
Total 30 30 
 
 
The incidence of post operative ileus was significantly lower in the 
case group when compared to the control group (p=0.049) 
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C. PULMONARY COMPLICATIONS 
 
PULMONARY COMPLICATION CASE CONTROL 
PNEUMONIA 0 4 
ATELECTASIS 2 2 
PULMONARY EDEMA 1 2 
PLEURAL EFFUSION 0 2 
TOTAL 3 10 
 
The pulmonary complications were significantly lower in the case 
group when compared to the control group (P= 0.028). 
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D. LENGTH OF HOSPITAL STAY (LOS) 
 The length of hospital stay is significantly lower in the case group 
as a result of significant reduction in the rate of complications like 
pulmonary complications, wound infections and post operative ileus. 
(p=0.014) 
LOS CASE CONTROL 
<10 24 15 
11 - 25 6 13 
26 - 40 0 0 
>40 0 2 
Total 30 30 
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Statistical analysis 
 Analysis was done using SOFTWARE- SPSS version 17. TEST 
applied : Chi square test 
Control case P value S/NS 
Wound infection    
9/30 3/30 P=0.0213 S 
Pulmonary 
complication 
   
10/30 3/30 P=0.028 S 
Length of stay    
(<10 days) 15/30 24/30 P=0.047 S 
(11-25days) 13/30 6/30 P=0.047 S 
(26-40days) 0/30 0/30   
(>40days) 2/30 0/30 P=0.553 NS 
Post op ileus    
(9/30 days) 3/30 P=0.04 S 
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DISCUSSION 
 
In this study 60 patients (30 cases and 30 controls) who underwent 
emergency gastrointestinal surgeries in acute abdomen presenting within 
24 hours were studied post operatively. In control group oral feeding was 
started according to the standard practice of 
1. Appearance of bowel sounds 
2. Ryles tube aspirate less than 150ml 
In study group early entereal feeding was started within 48hours by 
oral or via ryles tube. 
In our study, as we have seen the most common case operated was 
Early duodenal perforation. (40 % ) in case and control group. 
In case group wound infection was also significantly lesser 
(p=0.0213) which gives a results as same as that of study by Moore et al 
Annals of surgery 1992;216:172-83 
Post operative ileus was significantly lesser (p=0.049) in patients 
who were given early enteral feeding which was consistent with the study 
by N Kaur, MK Gupta, VR Minocha, World Journal of Surgery 
2005:29:1023-7 
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The follow up of the patients revealed that the rates of pulmonary 
compliations like pneumonia, atelectasis, pleural effusions was found to 
be significantly more in control group who were kept in starvation for 
around 6 days with parentral fluids only and with no immunomodulatory 
effects of nutrition.(p=0.028). 
This finding was consistent with the study by HS Lee, H Shim, JY 
Jhang, H Lee, JG Lee in the Yonsei Medical Journal July 11, 2013 
Compiling the results of the above complications the length of 
hospital stay among the case group was also significantly low. (p=0.014) 
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SUMMARY 
 
 This is a prospective study conducted on cases who under went 
emergency gastro intestinal surgeries in Department of General 
Surgery, Madurai Medical College, Madurai. 
 The most common case operated was early duodenal perforation 
 A total of 60 cases were studied and the post operative outcome was 
documented and analysed 
 The rates of complications (pulmonary complications(p=), wound 
infections(p=) and ileus(p=) () and length of hospital stay was 
found to be significantly lower in the Early enteral feeding                  
group (p) 
 
 
 
  
75 
 
CONCLUSION 
 
In this study we have documented and analysed cases patients 
undergoing emergency gastrointestinal surgeries and studied the outcome 
of early enteral feeding versus late enteral feeeding in such patients. The 
post-operative follow up and documentation of various complications in 
the post-operative period were noted and statistically analysed comparing 
the case and control group. In conclusion we infer that. 
 Early enteral feeding is feasible in patients undergoing emergency 
gastrointestinal surgeries post operatively. 
 The rates of complications like pulmonary complications, wound 
infections and ileus in post-operative patients is found to be 
significantly lower in the Early enteral feeding group 
 The length of hospital stay in patients started on early enteral feeds 
were significantly lower. 
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 PROFORMA 
 
Name  :           I.P. No :  Age : Unit  : 
Sex  : D.O.A : 
Occupation : D.O.D : 
Address : 
Phone No : D.O. Surgery 
CHIEF COMPLAINTS 
1) Abdominal Pain   : 
2) Bleeding PR   : 
3) Constipation   : 
4) Tenesmus    : 
5) altered bowel habits  : 
6) Loss of Appetite   : 
7) Weight Loss   : 
8) Abdominal distension  : 
 
 PAST HISTORY: 
1) History of similar complaints 
2) Treatment taken 
3) History of Drug intake 
4) History suggestive of Hypertension / Diabetes / Tuberculosis / 
heart disease / jaundice / thyroid disorder. 
PERSONAL HISTORY 
Diet : Vegetarian / Mixed 
Habits : Smoking / Alcohol / Tobacco Bowel habits 
Bladder Sleep 
FAMILY HISTORY 
Relevant / Not MENSTRUAL HISTORY 
Amenorrhoea / menorrhagia 
Regular / Not Duration 
Associated / Not with pain L.M.P. 
 
 
 GENERAL PHYSICAL EXAMINATION  
1. General survey 
2. Body build and nourishment 
3. Appearance 
4. Attitude : Restless / Quiet 
5. Dehydration : Mild/ Moderate / Severe / Nil 
6. Anaemia / Jaundice / Clubbing Cyanosis / Lymphadenopathy / 
Pedal oedema. 
7. Eye signs 
8. Skin Changes 
9. Pulse 
10. Temperature 
11. Respiratory rate 
12. Blood pressure SYSTEMIC EXAMINATION 
 Cardiovascular system 
 Respiratory System 
 Central nervous system 
 Genito - urinary system 
 Abdomen INVESTIGATIONS:- 
 
 
 1. Blood : Hb% 
2. TLC 
3. DLC 
4. BT 
5. CT 
6. ESR 
7. Blood group and rh type. 
8. Urine : Albumin / Sugar / Microscopy 
9. Blood : sugar / Urea / creatinine 
10. ECG 
11. USG abdomen and pelvis 
12. CECT Abdomen/pelvis 
13. Colonoscopy 
14. HPE 
15. HIV 
16. HbsAg 
17. Others DIAGNOSIS MANAGEMENT SURGICAL 
 Pre-operative instructions Type of Anaesthesia 
Post - operative instructions 
Post - operative period/Post - operative complication management 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MASTER CHART 
CASE 
S
L
.N
O
 
N
A
M
E
 
A
G
E
 
S
E
X
 
IP
 N
O
 
D
IA
G
N
O
S
IS
 
P
R
O
C
E
D
U
R
E
 
P
U
L
M
O
N
A
R
Y
 
C
O
M
P
L
IC
A
T
IO
N
 
L
O
S
 
W
O
U
N
D
 
IN
F
E
C
T
IO
N
 
P
O
S
T
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P
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E
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1 AZHAGUVALLI 59 FEMALE 5057 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 7 YES - 
2 KRISHNAN 47 MALE 98442 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 8 YES - 
3 KARUPAYEE 65 FEMALE 65352 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 8 YES - 
4 ALAGAMMAL 55 FEMALE 64116 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 12 YES YES 
5 ANDISAMY 47 MALE 17031 
SUB ACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS - 7 - - 
6 ADAIKKALAM 65 MALE 159826 SIGMOID GROWTH COLOSTOMY - 15 YES - 
 7 PERIYAVEETHI 59 FEMALE 60555 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 5 YES - 
8 PONNALAGU 80 FEMALE 1146084 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 9 - - 
9 NAGAMANI 53 FEMALE 1145965 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE YES 8 - - 
10 SHANMUGAM 55 MALE 14998 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 9 YES - 
11 SASIREKHA 60 FEMALE 1142404 
SUB ACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS - 5 YES - 
12 CHANDRASEKAR 68 MALE 55482 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 12 YES - 
13 KANNAN 61 MALE 12410 SIGMOID VOLVULUS 
HARTMANNS 
PROCEDURE 
- 14 YES - 
14 VALLIRAJA 62 MALE 1136881 SIGMOID GROWTH COLOSTOMY - 7 - YES 
15 MURUGAN 50 MALE 57533 
SUB ACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS - 14 YES - 
16 SHANTHI 52 FEMALE 57298 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 5 - - 
 17 VIJAYENDRAN 49 MALE 9915 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 8 YES - 
18 RAJU 62 MALE 123651 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 10 YES - 
19 PERIYAPANDI 52 MALE 112682 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 7 - - 
20 AMMALU 63 FEMALE 112682 
SUB ACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS - 9 - - 
21 KANDASAMY 60 MALE 1127357 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 5 YES - 
22 KASIRAJAN 71 MALE 1127361 
DESCENDING COLON 
GROWTH 
COLOSTOMY - 8 YES YES 
23 AMMALU 65 FEMALE 1120759 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 12 YES - 
24 RAMALAKSHMI 45 FEMALE 1124625 
DESCENDING COLON 
GROWTH 
COLOSTOMY - 11 - - 
25 KANNAN 45 MALE 6328 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 7 - - 
 26 AANDISAMY 78 MALE 56432 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE YES 8 - - 
27 MUTHUIRULAN 57 MALE 1105627 
SUB ACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 8 YES - 
28 MUTHUSAMY 76 MALE 1104723 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 10 YES - 
29 DOMINIC 64 MALE 1104284 SIGMOID VOLVULUS 
HARTMANNS 
PROCEDURE 
- 5 - - 
30 RAJAVALLI 52 FEMALE 109812 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 7 - - 
 
 
 
 
 
 CONTROL 
SL.
NO 
NAME 
A
G
E 
SEX 
IP 
NO 
DIAGNOSIS PROCEDURE 
PULMON
ARY 
COMPLIC
ATION 
LOS 
WOUND 
COMPLIC
ATION 
POST 
OP 
ILEUS 
1 BALAJI 40 MALE 
11009
8 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE YES 8 YES - 
2 MARY 57 FEMALE 
10937
86 
SIGMOID COLON 
GROWTH 
COLOSTOMY YES 6 YES - 
3 MAHARAJA 49 MALE 
10951
08 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 12 YES - 
4 AMARAVATHY 78 FEMALE 
10947
69 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS YES 11 YES - 
5 SARASWATHI 70 FEMALE 
10947
63 
DESCNDING COLON 
GROWTH 
COLOSTOMY YES 7 - - 
6 MALAISAMY 62 MALE 566 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 17 YES - 
7 KANNAN 50 MALE 1094 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 11 YES YES 
8 AYYAPPAN 49 MALE 2467 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 22 YES - 
9 CHINNARASSU 48 MALE 1291 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 13 YES - 
10 SELVAM 43 MALE 2681 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 7 - - 
 11 THANGARAJ 42 MALE 
10931
67 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS YES 9 YES - 
12 MARIMUTHU 48 MALE 
10768
4 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS YES 13 YES - 
13 THANGAVEL 53 MALE 
10384
12 
SIGMOID COLON 
GROWTH 
COLOSTOMY - 6 - - 
14 SELVARAJ 60 MALE 1094 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE YES 8 YES YES 
15 AYYAVOO 60 MALE 821 
SIGMOID COLON 
GROWTH 
COLOSTOMY YES 44 YES - 
16 RASU 50 MALE 682 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 12 - - 
17 THANGAPANDI 35 MALE 
10945
72 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
ADHESIOLYSIS YES 7 YES - 
18 PANDIAMMAL 60 FEMALE 29956 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 8 - - 
19 PONGODHAI 40 FEMALE 
12865
14 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE - 11 YES - 
20 SILAMBATHURAI 61 MALE 10099 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 19 YES - 
21 SATHAIYYAL 61 MALE 
10936
29 
SIGMOID COLON 
GROWTH 
COLOSTOMY YES 11 YES - 
 22 GANAPATHIRAJA 41 MALE 4821 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 12 YES - 
23 SUNDARAPANDI 54 MALE 685 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
PRIMARY 
CLOSURE 
YES 7 YES YES 
24 GANESAN 48 MALE 271 
DESCNDING COLON 
GROWTH 
COLOSTOMY YES 13 - - 
25 SUSHEELA 48 FEMALE 1093 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE YES 11 YES - 
26 MANIKANDAN 49 MALE 402 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
- 9 YES - 
27 AANDISAMY 52 MALE 820 
SUBACUTE 
INTESTINAL 
OBSTRUCTION 
BAND RELEASE YES 7 - - 
28 MARIYYAMMAL 41 FEMALE 
10931
12 
SIGMOID 
VOLVULUS 
HARTMANNS 
PROCEDURE 
YES 6 YES 
 
- 
29 PALANIVELU 50 MALE 
10939
72 
EARLY DUODENAL 
PERFORATION 
PRIMARY 
CLOSURE 
YES 7 YES - 
30 
SHARATH 
KUMAR 
 
42 
MALE 
10942
59 
SIGMOID 
VOLVULUS 
HARTMANNS 
PROCEDURE 
YES 7 - - 
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